Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...
It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.
Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...
5d
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new ...
Manu Subhashchandrabose built an AI validation framework for enterprise systems, using predictive testing, self-healing automation, drift monitoring, and continuous validation to make probabilistic AI ...
The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new ...
Developed in South Korea, the explainable AI outperformed the conventional CAIDE Dementia Risk Score in both detection and ...
This article explores the evolving role of NHP models in drug development, examining when they remain scientifically ...
Combining engineered human tissue with high-content imaging, robotics and AI-driven control can help make drug testing more ...
Cizzle Bio Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, has announced the publication of new peer-reviewed research supporting the clinical utility of the ...
Ricky Williams is synonymous with Dolphins running backs, but he didn't get the No. 1 spot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results